| Item Type | Name |
|
Academic Article
|
Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation.
|
|
Academic Article
|
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.
|
|
Academic Article
|
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
|
|
Academic Article
|
Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab.
|
|
Academic Article
|
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.
|
|
Academic Article
|
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
|
|
Academic Article
|
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.
|
|
Academic Article
|
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.
|
|
Academic Article
|
Clofarabine ? fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
|
|
Academic Article
|
Cord-blood engraftment with ex vivo mesenchymal-cell coculture.
|
|
Concept
|
Blood Donors
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Blood Transfusion, Autologous
|
|
Concept
|
Fetal Blood
|
|
Concept
|
Blood Cell Count
|
|
Concept
|
ABO Blood-Group System
|
|
Concept
|
Cord Blood Stem Cell Transplantation
|
|
Concept
|
Blood Preservation
|
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
|
Concept
|
Blood Group Incompatibility
|
|
Concept
|
Blood
|
|
Concept
|
Blood Volume
|
|
Concept
|
Blood Banks
|
|
Concept
|
Blood Transfusion
|
|
Concept
|
Blood Platelets
|
|
Academic Article
|
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.
|
|
Academic Article
|
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
|
|
Academic Article
|
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
|
|
Academic Article
|
Low rate of infusional toxicity after expanded cord blood transplantation.
|
|
Academic Article
|
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.
|
|
Academic Article
|
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.
|
|
Academic Article
|
Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center.
|
|
Academic Article
|
Concise review: umbilical cord blood transplantation: past, present, and future.
|
|
Academic Article
|
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.
|
|
Academic Article
|
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
|
|
Academic Article
|
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.
|
|
Academic Article
|
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
|
|
Academic Article
|
Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
|
|
Academic Article
|
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
|
|
Academic Article
|
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
|
|
Academic Article
|
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
|
|
Academic Article
|
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
|
|
Academic Article
|
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
|
|
Academic Article
|
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
|
|
Academic Article
|
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
|
|
Academic Article
|
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers.
|
|
Academic Article
|
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
|
|
Academic Article
|
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
|
|
Academic Article
|
Hyperacute GVHD: risk factors, outcomes, and clinical implications.
|
|
Academic Article
|
Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT.
|
|
Academic Article
|
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
|
|
Academic Article
|
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation.
|
|
Academic Article
|
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.
|
|
Academic Article
|
Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.
|
|
Academic Article
|
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation.
|
|
Academic Article
|
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid.
|
|
Academic Article
|
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.
|
|
Academic Article
|
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
|
|
Academic Article
|
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.
|
|
Academic Article
|
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
|
|
Academic Article
|
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
|
|
Academic Article
|
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma.
|
|
Academic Article
|
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.
|
|
Academic Article
|
Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center.
|
|
Academic Article
|
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
|
|
Academic Article
|
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma.
|
|
Academic Article
|
Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease.
|
|
Academic Article
|
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.
|
|
Academic Article
|
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.
|
|
Academic Article
|
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.
|
|
Academic Article
|
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
|
|
Academic Article
|
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.
|
|
Academic Article
|
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.
|
|
Academic Article
|
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.
|
|
Academic Article
|
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
|
|
Academic Article
|
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
|
|
Academic Article
|
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.
|
|
Academic Article
|
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
|
|
Academic Article
|
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
|
|
Academic Article
|
A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.
|
|
Academic Article
|
Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patients.
|
|
Academic Article
|
Is there an expiration date for a cord blood unit in storage?
|
|
Academic Article
|
Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease.
|
|
Academic Article
|
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
|
|
Academic Article
|
General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.
|
|
Academic Article
|
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment.
|
|
Academic Article
|
Umbilical cord blood graft engineering: challenges and opportunities.
|
|
Academic Article
|
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
|
|
Academic Article
|
Better allele-level matching improves transplant-related mortality after double cord blood transplantation.
|
|
Academic Article
|
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for?Patients with Chronic Myelomonocytic Leukemia.
|
|
Academic Article
|
Romidepsin targets multiple survival signaling pathways in malignant T cells.
|
|
Academic Article
|
Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials.
|
|
Academic Article
|
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.
|
|
Academic Article
|
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell?Transplantation for Relapsed and Refractory Hodgkin?Lymphoma.
|
|
Academic Article
|
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
|
|
Academic Article
|
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas
|
|
Academic Article
|
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, andSoft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation
|
|
Academic Article
|
Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning
|
|
Academic Article
|
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma
|
|
Academic Article
|
Better allele-level matching improves transplant-related mortality after double cord blood transplantation
|
|
Academic Article
|
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
|
|
Academic Article
|
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation
|
|
Academic Article
|
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia
|
|
Academic Article
|
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation
|
|
Academic Article
|
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia
|
|
Academic Article
|
Biology of Blood and Marrow Transplantation
|
|
Academic Article
|
General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation
|
|
Academic Article
|
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30<sup>+</sup> Lymphoma Patients Who Received Multiple Prior Lines of Treatment
|
|
Academic Article
|
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival forPatients with Chronic Myelomonocytic Leukemia
|
|
Academic Article
|
Umbilical cord blood graft engineering
|
|
Academic Article
|
Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients
|
|
Academic Article
|
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma
|
|
Academic Article
|
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.
|
|
Academic Article
|
Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.
|
|
Academic Article
|
Vigorous exercise mobilizes CD34+ hematopoietic stem cells to peripheral blood via the ?2-adrenergic receptor.
|
|
Academic Article
|
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.
|
|
Academic Article
|
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma.
|
|
Academic Article
|
Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index.
|
|
Academic Article
|
Outcomes of Haploidentical Stem Cell Transplantation for?Lymphoma with Melphalan-Based Conditioning.
|
|
Academic Article
|
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia.
|
|
Academic Article
|
Long-Term Outcomes after Treatment with Clofarabine???Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
|
|
Academic Article
|
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.
|
|
Academic Article
|
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network.
|
|
Academic Article
|
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
|
|
Academic Article
|
Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.
|
|
Academic Article
|
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.
|
|
Academic Article
|
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.
|
|
Academic Article
|
Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.
|
|
Academic Article
|
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
|
|
Academic Article
|
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma.
|
|
Academic Article
|
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
|
|
Academic Article
|
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.
|
|
Academic Article
|
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.
|
|
Academic Article
|
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations.
|
|
Academic Article
|
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
|
|
Academic Article
|
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.
|
|
Academic Article
|
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.
|
|
Concept
|
Peripheral Blood Stem Cells
|
|
Academic Article
|
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
|
|
Academic Article
|
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
|
|
Academic Article
|
Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.
|
|
Academic Article
|
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
|
|
Academic Article
|
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity.
|
|
Academic Article
|
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.
|
|
Academic Article
|
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL.
|
|
Academic Article
|
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM.
|
|
Academic Article
|
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients.
|
|
Academic Article
|
Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood banking.
|
|
Academic Article
|
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.
|
|
Academic Article
|
Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
|
|
Academic Article
|
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
|
|
Academic Article
|
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities.
|
|
Academic Article
|
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma.
|
|
Academic Article
|
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.
|
|
Academic Article
|
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies.
|